BioPharma

13 November, 2026 | Friday | News

Eppendorf Bets €40 Million on Malaysia as New Manufacturing Hub

Eppendorf SE marked the start of construction on its new production facility at Bandar Cassia Technology Park in Penang. The groundbreaking marks a major step in the company’s expansion in Malaysia and es...

Lab

11 November, 2026 | Wednesday | News

Pierre Fabre and XtalPi Partner on AI-Driven Oncology Drug Discovery

Laboratoires Pierre Fabre and XtalPi (XtalPi Holdings Limited, 2228.HK) are pleased to announce an agreement under which they will collaborate on the discovery of novel clinical candidates across a number of re...

BioTech

16 November, 2026 | Monday | News

Zai Lab Secures China NRDL Coverage for Five Medicines, Including Two New Listings

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, announced that five of its commercial medicines in China have been included in the country's 2026 National Reimburseme...

Contract Services

04 November, 2026 | Wednesday | News

Lonza to Acquire Five US CDMO Sites from Merck KGaA to Double Manufacturing Footprint

Lonza acquires five CDMO manufacturing sites and approximately 1,100 highly skilled employees, more than doubling its US footprint to nine CDMO sites with a US workforce of more than 6,000 employees. Transac...

Consumer Health

13 November, 2026 | Friday | News

Pfizer Secures Up to $1.5 Billion From Blackstone to Advance Monthly GLP-1 Programme

Blackstone to provide Pfizer up to $1.5 billion through 2028 to support clinical program for GLP-1 receptor agonist Pfizer Inc. (NYSE: PFE) and Blackstone Life Sciences (“Blackstone”)announced a st...

Medtech

17 November, 2026 | Tuesday | News

Thailand Approves YONDELIS for Advanced Soft Tissue Sarcoma

Independent biopharmaceutical company Specialised Therapeutics announced that the Thailand Food and Drug Administration approved YONDELIS® (trabectedin) on 24 July 2026 for the treatment of adult patie...

Cell & Gene

12 November, 2026 | Thursday | Expert Insight

Scaling Personalised Therapies Across APAC Starts With Supply Chain Readiness

As cell and gene therapies advance across Asia-Pacific, supply chains must connect complex manufacturing processes with individual patients’ treatment schedules. In this BioPharma APAC interview, Mervin S...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close